01 1Astellas Pharma Canada Inc.
02 2CT Corporation System Canada Ltd.
03 2Sigma-Tau Pharmaceuticals Inc.
01 21336890
02 11338701
03 11338736
04 11339008
01 2Amphotericin B
02 2Amphotericin B Lipid Complex
03 1Liposomal Amphotericin B
01 2Intravenous Injection
02 1Lyophilized powder for reconsititution
03 2Powder for Reconstitution
01 22012-09-05
02 12013-11-12
03 12013-11-26
04 12014-03-25
Patent Expiration Date : 2014-03-25
Date Granted : 1997-03-25
Brand Name : AMBISOME
Patent Number : 1339008
Filing Date : 1988-11-10
Strength per Unit : 50 mg amphotericin B per vial
Dosage Form : Lyophilized powder for reconsititution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2014-03-25
Date Granted : 1997-03-25
Patent Expiration Date : 2013-11-12
Date Granted : 1996-11-12
Brand Name : ABELCET
Patent Number : 1338701
Filing Date : 1988-02-29
Strength per Unit : 5mg/ml
Dosage Form : Intravenous Injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2013-11-12
Date Granted : 1996-11-12
Patent Expiration Date : 2013-11-26
Date Granted : 1996-11-26
Brand Name : ABELCET
Patent Number : 1338736
Filing Date : 1987-12-01
Strength per Unit : 5mg/ml
Dosage Form : Intravenous Injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2013-11-26
Date Granted : 1996-11-26
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Brand Name : AMPHOTEC
Patent Number : 1336890
Filing Date : 1988-02-29
Strength per Unit : 50mg VIAL
Dosage Form : Powder for Reconstitution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Brand Name : AMPHOTEC
Patent Number : 1336890
Filing Date : 1988-02-29
Strength per Unit : 100mg VIAL
Dosage Form : Powder for Reconstitution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
